SYNTAX Score and Long-Term Outcomes: The BARI-2D Trial.
Journal of the American College of Cardiology.
Times cited: 3
- Quality Control Measures over 30 Years in a Multicenter Clinical Study: Results from the Diabetes Control and Complications Trial / Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study. PloS one. 2015 Academic Article GET IT
Sex, Prescribing Practices and Guideline Recommended, Blood Pressure, and LDL Cholesterol Targets at Baseline in the BARI 2D Trial.
International journal of endocrinology.
Times cited: 3
- Change in albuminuria and eGFR following insulin sensitization therapy versus insulin provision therapy in the BARI 2D study. Clinical journal of the American Society of Nephrology : CJASN. 2014 Academic Article GET IT
- High prevalence and diversity of kidney dysfunction in patients with type 2 diabetes mellitus and coronary artery disease: the BARI 2D baseline data. The American journal of the medical sciences. 2010 Academic Article GET IT
Prolonged effect of intensive therapy on the risk of retinopathy complications in patients with type 1 diabetes mellitus: 10 years after the Diabetes Control and Complications Trial.
Archives of Ophthalmology.
Times cited: 206
Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT).
The Journal of Pediatrics.
Times cited: 270
- Bromocriptine as primary therapy for prolactin-secreting macroadenomas: results of a prospective multicenter study. The Journal of clinical endocrinology and metabolism. 1985 Academic Article GET IT
- Bromocriptine as primary therapy for prolactin secreting macroadenomas; results of a prospective multicenter study. Obstetrical and Gynecological Survey. 1985 Academic Article